These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17429142)

  • 1. CD31 and CD34 expression as immunohistochemical markers of endothelial transdifferentiation in human cutaneous melanoma.
    Pisacane AM; Picciotto F; Risio M
    Cell Oncol; 2007; 29(1):59-66. PubMed ID: 17429142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical Study of Vasculogenic Mimicry and Angiogenesis in Melanocytic Tumors of the Eye and the Periocular Area.
    Spiliopoulos K; Peschos D; Batistatou A; Ntountas I; Papoudou-Bai A; Zioga A; Agnantis N; Kitsos G
    Anticancer Res; 2017 Mar; 37(3):1113-1120. PubMed ID: 28314272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma.
    Massi D; Franchi A; Paglierani M; Ketabchi S; Borgognoni L; Reali UM; Santucci M
    Hum Pathol; 2004 Apr; 35(4):496-502. PubMed ID: 15116332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas.
    Pisacane AM; Risio M
    Melanoma Res; 2005 Feb; 15(1):39-43. PubMed ID: 15714119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34(+) fibrocytes in melanocytic nevi and malignant melanomas of the skin.
    Wessel C; Westhoff CC; Nowak K; Moll I; Barth PJ
    Virchows Arch; 2008 Nov; 453(5):485-9. PubMed ID: 18813945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.
    Maniotis AJ; Folberg R; Hess A; Seftor EA; Gardner LM; Pe'er J; Trent JM; Meltzer PS; Hendrix MJ
    Am J Pathol; 1999 Sep; 155(3):739-52. PubMed ID: 10487832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
    Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
    Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y expression in cutaneous melanoma.
    Gilaberte Y; Roca MJ; Garcia-Prats MD; Coscojuela C; Arbues MD; Vera-Alvarez JJ
    J Am Acad Dermatol; 2012 Jun; 66(6):e201-8. PubMed ID: 21620518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential.
    Wu H; Barusevicius A; Babb J; Klein-Szanto A; Godwin A; Elenitsas R; Gelfand JM; Lessin S; Seykora JT
    J Cutan Pathol; 2005 Feb; 32(2):125-30. PubMed ID: 15606670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple combinations of melanocytic and vascular endothelial markers enhance the detection rate of lymphovascular invasion in cutaneous melanoma.
    Bayram A; Ozturk Sari S; Ozluk Y; Tas F; Buyukbabani N
    J Cutan Pathol; 2021 Apr; 48(4):472-478. PubMed ID: 32935876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of vascular endothelial growth factor expression with patohistological parameters of cutaneous melanoma.
    Gacević M; Jović M; Zolotarevski L; Stanojević I; Novaković M; Miller K; Šuljagić V; Mijušković Ž; Vojvodić D
    Vojnosanit Pregl; 2016 May; 73(5):449-57. PubMed ID: 27430109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial association of melanocytic naevus and melanoma.
    Urso C; Giannotti V; Reali UM; Giannotti B; Bondi R
    Melanoma Res; 1991; 1(4):245-9. PubMed ID: 1823633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.
    Mehregan DR; Hamzavi I
    Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of galanin in melanocytic tumors].
    Gilaberte Y; Vera J; Coscojuela C; Roca MJ; Parrado C; González S
    Actas Dermosifiliogr; 2007; 98(1):24-34. PubMed ID: 17374330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
    Špirić Z; Eri Ž; Erić M
    Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression.
    Krengel S; Grotelüschen F; Bartsch S; Tronnier M
    J Cutan Pathol; 2004 Jan; 31(1):1-7. PubMed ID: 14675278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiosarcoma: a tissue microarray study with diagnostic implications.
    Rao P; Lahat G; Arnold C; Gavino AC; Lahat S; Hornick JL; Lev D; Lazar AJ
    Am J Dermatopathol; 2013 Jun; 35(4):432-7. PubMed ID: 23689692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J; Cronin F; Duncan LM
    Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Clark's nevus.
    Marchesi L; Naldi L; Locati F; Tribbia G; Pezzica E; Parma A; Cainelli T
    Am J Dermatopathol; 1994 Aug; 16(4):364-71. PubMed ID: 7978065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.